Seres Therapeutics
Price & Volume
Stats
See more52W Range | $7.17-$30.60 |
Market Cap | $81.1M |
Shares Short | 15M |
Financials
See moreRevenue (12 Mos) | $126.3M |
Revenue Growth (YoY) | -93.4% |
Gross Profit (12 Mos) | -$14.5M |
Diluted EPS | -$16.20 |
News
See moreYahoo Finance • 2 months ago
Seres Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
Yahoo Finance • last year
11 Oversold NASDAQ Stocks To Buy Right Now
Yahoo Finance • last year
Seres Therapeutics, Inc. (NASDAQ:MCRB) is a favorite amongst institutional investors who own 62%
About
CEO | Mr. Eric D. Shaff M.B.A. |
CFO | Ms. Marella Thorell CPA |
Address | 101 Cambridgepark Drive, Cambridge, MA, United States, 02140 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 103 |
